Skip to main content
. 2020 May 5;15(5):e0225290. doi: 10.1371/journal.pone.0225290

Fig 3. Verification that TFAP2C is the target gene of miRNA193.

Fig 3

A: qPCR detection of differential expression of miRNA193 and TFAP2C in different cells. B: TargentScan 7.2 predicts the targeting relationship between TAFAP2C and miRNA193, and its dual luciferase experimental mutation site. C: Dual luciferase assay for targeted binding of miRNA193 to TFAP2C. D: Changes in resistance to cisplatin in esophageal cancer cells after addition of TE1/DDP-Exo, transfection of miRNA193 minic or TFAP2C siRNA.